Lung Cancer Home > Mechlorethamine Chemotherapy Information

Mechlorethamine (Mustargen®) is a prescription medicine approved for the treatment of lung cancer and certain blood and bone marrow cancers. It is also licensed to help treat metastatic cancer associated with effusion. Metastatic cancer is cancer that has spread from its original site to other areas of the body. Effusion occurs when excess fluid builds up in the space between membranes that line body organs, such as the lungs or abdomen (stomach).
This medication is usually given as an injection into a vein (an intravenous, or IV, injection), although it may also be given directly into body cavities (the lining of the lungs, heart, or abdomen).
Before beginning chemotherapy treatment with mechlorethamine, make sure to review the safety information with your healthcare provider. For example, you may not be able to use this medicine if you have an infection, gout, or certain other medical conditions. Also, this drug may react with a few other medications.
(For more information on this chemotherapy drug, click Mechlorethamine. This article takes a closer look, including details on how it works, dosing guidelines, and possible side effects.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.